1130759-48-6

Basic information

• Product Name: 5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE
• Synonyms: 1-(5-BROMO-PYRIDIN-2-YL)-4-METHYL-PIPERAZINE;5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE
• CAS NO: 1130759-48-6
• Molecular Formula: C10H14BrN3
• Molecular Weight: 256.14
• Mol File: 1130759-48-6.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE(1130759-48-6)
• EPA Substance Registry System: 5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE(1130759-48-6)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• Hazardous Substances Data: 1130759-48-6(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-(4-methylpiperazin-1-yl)pyridine is a chemical compound with the molecular formula C11H14BrN3. It is a pyridine derivative containing a bromine atom and a piperazine ring with a methyl group attached. 5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials science. It has also been investigated for its potential use in the treatment of various diseases, including cancer and neurological disorders. Additionally, 5-Bromo-2-(4-methylpiperazin-1-yl)pyridine has been studied for its biological and pharmacological properties, making it a valuable tool for research in drug discovery and development.

Upstream product

• 109-01-3 1-methyl-piperazine 
• 625-92-3 3,5-dibromopyridine 

Relevant articles and documents

METHODS OF USING INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS

This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.

INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF

Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt path

5, 7-DIHYDRO- 6H-PYRIMIDO [ 5, 4-D] [ 1 ] BENZAZEPIN-6-THIONES AS PLK INHIBITORS

This invention provides compounds of formula I: wherein R1, R2, R3, R4, R5, and R6 are as described in the specification. The compounds are inhibitors of PLK and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.